BioNTech SE - ADR BNTX shares are trading higher by 4.66% to $106.51 Wednesday morning as the stock continues to rebound after falling on Monday. Traders and investors are likely weighing the company's second-quarter report from Monday's pre-market session.
What Happened Monday?
BioNTech SE announced second-quarter revenues of €167.7 million, a decline from €3.2 billion in the previous year. Total revenues for the six months ending June 30, 2023, were €1.44 billion, compared to €9.6 billion for the same period in the prior year.
The reduction in BioNTech's second-quarter revenues is attributed to write-offs by collaboration partner Pfizer Inc, leading to a notable decrease in the company's gross profit share for the quarter...Read More
According to data from Benzinga Pro, BNTX has a 52-week high of $188.98 and a 52-week low of $95.50.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
